PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences (Nasdaq:OCLS) announced that its CEO and founder, Hoji Alimi, was today’s featured guest on the NASDAQ CEO Signature Series webcast hosted by financial reporter, Sasha Salama. In the interview, Mr. Alimi discussed the company’s recent milestones including positive results from the U.S. Phase II clinical study of Microcyn® Technology in patients with mildly infected diabetic foot ulcers; the approval of Microcyn by China’s State Food and Drug Administration (SFDA); and the company’s global commercialization efforts.
